| India |
 |
newsR > Press Releases > American Arbitration Association Panel Finds in Favor of Adocia in First Phase of Arbitration against Eli Lilly
LYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Paris:ADOC) (Euronext Paris: FR0011184241 – ADOC), the biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of approved proteins, announced today that the Arbitration Panel presiding over Adocia’s arbitration claims against Eli Lilly & Company (“Lilly”) has found in favor of Adocia on the first of the claims to be resolved, awarding Adocia USD 11.6 million, as compensa
Will Smoking Be a Thing of the Past by 2030?
Space Jam 2 Is Officially Happening - Again
Trump Wants to Build a New Wall - And Not in the U.S.
Sony Leaps Into the Classic Console Game With Its Mini PlayStation
Will There Be a Second Referendum on Brexit? Here We Go Again
Elon Musk and the 'Pedo Guy' Saga - He's Getting Sued, Now
Is the Apple Watch As Healthy As It’s Cracked Up to Be?
Is the UK About to Get Its Own Version of Netflix?| Environmentally friendly: newsR is hosted on servers powered solely by renewable energy |
| © 2018 newsR / One News Page Ltd. All Rights Reserved. | About us | Disclaimer | Terms & Conditions | Content Accreditation RSS | News for my Website | Free news search widget | Help | Contact us | DMCA / Content Removal | Privacy & Data Protection Policy How are we doing?  Send us your feedback | LIKE us on Facebook FOLLOW us on Twitter |